O Shaughnessy Asset Management LLC Increases Holdings in LifeVantage Co. (NASDAQ:LFVN)

O Shaughnessy Asset Management LLC raised its position in LifeVantage Co. (NASDAQ:LFVN - Free Report) by 56.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 93,576 shares of the company's stock after purchasing an additional 33,658 shares during the period. O Shaughnessy Asset Management LLC owned 0.75% of LifeVantage worth $1,640,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of LFVN. HighTower Advisors LLC acquired a new position in shares of LifeVantage in the 3rd quarter valued at $638,000. Barclays PLC boosted its holdings in shares of LifeVantage by 38.2% in the 3rd quarter. Barclays PLC now owns 41,966 shares of the company's stock valued at $507,000 after buying an additional 11,608 shares in the last quarter. Ritholtz Wealth Management boosted its holdings in shares of LifeVantage by 65.2% in the 4th quarter. Ritholtz Wealth Management now owns 47,348 shares of the company's stock valued at $830,000 after buying an additional 18,682 shares in the last quarter. Copeland Capital Management LLC acquired a new position in shares of LifeVantage in the 4th quarter valued at $65,000. Finally, Bank of New York Mellon Corp boosted its holdings in shares of LifeVantage by 43.9% in the 4th quarter. Bank of New York Mellon Corp now owns 74,183 shares of the company's stock valued at $1,300,000 after buying an additional 22,620 shares in the last quarter. 35.32% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at LifeVantage

In other LifeVantage news, Director Raymond B. Greer sold 8,000 shares of LifeVantage stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $20.15, for a total value of $161,200.00. Following the sale, the director now owns 99,288 shares of the company's stock, valued at approximately $2,000,653.20. The trade was a 7.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 20.65% of the stock is owned by corporate insiders.

Analyst Ratings Changes

LFVN has been the subject of several research analyst reports. Craig Hallum initiated coverage on shares of LifeVantage in a report on Tuesday, January 14th. They issued a "buy" rating and a $35.00 target price for the company. Lake Street Capital began coverage on shares of LifeVantage in a research report on Thursday, December 19th. They set a "buy" rating and a $26.00 price objective on the stock.

LifeVantage Stock Down 12.0 %

LFVN stock traded down $1.84 during trading on Thursday, hitting $13.47. The company had a trading volume of 61,516 shares, compared to its average volume of 122,117. The firm has a market cap of $169.00 million, a PE ratio of 24.04 and a beta of 0.75. LifeVantage Co. has a 1-year low of $5.22 and a 1-year high of $27.38. The firm has a 50-day moving average price of $16.86 and a 200-day moving average price of $16.23.

LifeVantage (NASDAQ:LFVN - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.14 by $0.08. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date was Monday, March 3rd. LifeVantage's dividend payout ratio is presently 28.57%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.